Navigation Links
Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
Date:9/2/2008

tment of Cardiology, Hamilton Canada, co-principal investigator of the ATHENA study.

The most frequently reported adverse events of Multaq(R) vs. placebo in the ATHENA trial as seen in the pre-specified safety analysis, were gastrointestinal effects (26% vs. 22%), skin disorders (10% vs. 8%, mainly rash) and a mild increase in blood creatinine (4.7% vs. 1%) due to inhibition of tubular secretion of creatinine in the kidneys. The mechanism of blood creatinine increase was well defined in a separate study of healthy volunteers. In the ATHENA trial, compared to placebo, Multaq(R) showed a low risk of pro-arrhythmia and no excess of hospitalisations for congestive heart failure. There was a similar rate of study drug discontinuation between the 2 study groups.

About Atrial Fibrillation / Flutter and Stroke

Atrial Fibrillation (AF) is the most common cardiac arrhythmia in clinical practice and is one of the most important independent risk factors for stroke. Stroke is a major public health problem because this acute event often causes permanent neurological disabilities and death. Atrial fibrillation increases the risk of stroke by up to 5 times. It also is responsible for 15-20% of all strokes, which if caused by AF, are 2.2 times more likely to leave patients bedridden.

Atrial fibrillation is a major cause of hospitalisation and mortality and affects about 2.5 million people in the USA and 4.5 million people in the European Union. The Atrial Fibrillation Foundation expects the number of patients with AF to double in the next 20 years. Without appropriate management, atrial fibrillation can lead to serious complications, such as stroke and congestive heart failure.

About the ATHENA Study

The landmark ATHENA study is the only double-blind, anti-arrhythmic, morbidity-mortality study in patients with atrial fibrillation. It was conducted in more than 550 sites in 37 countries and enrolled a total of 4,628 patients.

The patie
'/>"/>

SOURCE Sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Intercell Announces Initiation of Further Phase II Clinical Trial of V710 an Investigational Vaccine to Prevent S. aureus Infection
2. Addrenex Pharmaceuticals New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation
3. Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in New Studies
4. Published Guidelines Further Support Use of Bioimpedance Measurement Technology for Early Assessment of Lymphedema
5. Further Clinical Testing of BZL101 in Advanced Breast Cancer Demonstrates Favorable Efficacy and Toxicity Profiles
6. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
7. New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients
8. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
9. GlaxoSmithKline Reports Further Progress of Oncology Portfolio
10. Arpida Provides Further Comments on the Pivotal Phase III Trials
11. Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... LOS ANGELES, Aug. 3, 2015  CytRx Corporation (NASDAQ: ... specializing in oncology, today reported financial results for the ... an overview of recent accomplishments and upcoming milestones for ... of 2015 has been very productive for CytRx. Enrollment ... of aldoxorubicin in soft tissue sarcoma (STS) continues on ...
(Date:8/3/2015)... SPRINGS, Florida , August 3, 2015 /PRNewswire/ ... HOLD -- FN Media Group LLC, PIV757417 The ... Focus on Developing Orphan Drug Products & Treatments ... now OFF HOLD. Distribution time: 3 Aug 2015 ... agreements between biotech companies, military surgical research and ...
(Date:8/3/2015)... Aug. 3, 2015  CytomX, a biopharmaceutical company ... today announced the promotion of several members of ... , who previously served as vice president of ... to senior vice president of corporate development and ... positions as the vice president of business development ...
Breaking Medicine Technology:CytRx Reports 2015 Second Quarter Financial Results 2CytRx Reports 2015 Second Quarter Financial Results 3CytRx Reports 2015 Second Quarter Financial Results 4CytRx Reports 2015 Second Quarter Financial Results 5CytRx Reports 2015 Second Quarter Financial Results 6CytRx Reports 2015 Second Quarter Financial Results 7CytRx Reports 2015 Second Quarter Financial Results 8CytRx Reports 2015 Second Quarter Financial Results 9CytRx Reports 2015 Second Quarter Financial Results 10CytRx Reports 2015 Second Quarter Financial Results 11CytRx Reports 2015 Second Quarter Financial Results 12CytRx Reports 2015 Second Quarter Financial Results 13CytRx Reports 2015 Second Quarter Financial Results 14/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 3/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 4/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 5/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 6CytomX Announces Management Team Promotions 2CytomX Announces Management Team Promotions 3
... 2011 Reportlinker.com announces that a new market research report ... In Vitro Diagnostics Market http://www.reportlinker.com/p0470752/World-In-Vitro-Diagnostics-Market.html ... through 2014 The Freedonia Group projects world ... annually to nearly $68 billion in 2014. Based on the ...
... Reportlinker.com announces that a new market research report ... European Markets for Patient Monitoring Devices and Equipment ... In 2010, the European patient monitoring ... 2008 and 2009. This mature market is expected ...
Cached Medicine Technology:Reportlinker Adds World In Vitro Diagnostics Market 2Reportlinker Adds World In Vitro Diagnostics Market 3Reportlinker Adds World In Vitro Diagnostics Market 4Reportlinker Adds World In Vitro Diagnostics Market 5Reportlinker Adds World In Vitro Diagnostics Market 6Reportlinker Adds World In Vitro Diagnostics Market 7Reportlinker Adds World In Vitro Diagnostics Market 8Reportlinker Adds World In Vitro Diagnostics Market 9Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 2Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 3Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 4Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 5Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 6Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 7Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 8Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 9Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 10Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 11Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 12Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 13Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 14Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 15Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 16Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 17Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 18Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 19Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 20Reportlinker Adds European Markets for Patient Monitoring Devices and Equipment 2011(15 Countries) 21
(Date:8/3/2015)... ... August 03, 2015 , ... Bayer has agreed to pay $56.9 million ... which a claimant alleged to have suffered an arterial blood clot including stroke and ... Yaz, Yasmin and Ocella, has been ongoing for well-over five years. In 2009, lawsuits ...
(Date:8/3/2015)... PA (PRWEB) , ... August 03, 2015 , ... ... Africa , Infectious diseases researchers from the University of Pittsburgh School of Medicine ... rollout of HIV prevention drugs in sub-Saharan Africa. , A cooperative agreement ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... Health notes that while an overwhelming number of Hispanics believe people can ... The overwhelming 70 percent of participants queried said making diet changes was important. ...
(Date:8/3/2015)... ... 2015 , ... Dental practice in Los Angeles , Sunset Plaza Dental, ... that general health emergencies, such as broken arms or a heart attack, should be ... turn to during a dental emergency. This is important, because dental trauma is extremely ...
(Date:8/3/2015)... ... August 03, 2015 , ... The art of preparing ... from her grandmother’s side at a young age, Nasreen Zereshki was extremely eager to ... to share her cookbook Recipes from My Persian Kitchen with the world. , Since ...
Breaking Medicine News(10 mins):Health News:Bayer Agrees To Settle Yaz Aterial Blood Clot Lawsuits 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 4Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 2Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 3Health News:Hispanics More Likely to Struggle with Misinformation About Diabetes 4Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2
... 5, 2011More mothers are breastfeeding their newborns, but for ... of breastfeeding for both mothers and infants. New observations ... breastfeed longer are presented in a collection of articles ... the Academy of Breastfeeding Medicine, published by Mary Ann ...
... By Lisa Esposito HealthDay Reporter , MONDAY, ... -- sending suggestive or explicit images by cellphone or ... Only a small minority of children reports transmitting ... than the rule, researchers say. In the ...
... (HealthDay News) -- A new study finds abuse in childhood ... research found that teens who,ve been abused or neglected have less ... some areas of the brain than those who haven,t been subjected ... history of abuse or neglect. They also had reductions of gray ...
... MONDAY, Dec. 5 (HealthDay News) -- When people with type ... third worrisome condition -- dementia -- goes up markedly, ... diabetes are twice as likely to develop dementia three to ... people with diabetes, researchers found. "We,ve known for years ...
... at Moffitt Cancer Center and colleagues have found that patients ... years after their therapy. The new study, published in the ... a follow-up to a study on fatigue and chemotherapy and ... in 2007. "Fatigue is among the most common ...
... MONDAY, Dec. 5 (HealthDay News) -- About one in ... according to new research. That number is up from ... Preventive asthma medications help control the airway disease before ... Education and Prevention Program recommend their use. "The ...
Cached Medicine News:Health News:Mothers are not reaching breastfeeding goals -- what needs to change? 2Health News:Teen 'Sexting' Might Be Less Common Than Feared 2Health News:Teen 'Sexting' Might Be Less Common Than Feared 3Health News:Abuse in Childhood May Alter Teen Brain 2Health News:Risk for Dementia Rises When Diabetes, Depression Meet: Study 2Health News:Risk for Dementia Rises When Diabetes, Depression Meet: Study 3Health News:Follow-up study finds prolonged fatigue for those who had chemotherapy for breast cancer 2Health News:More Children Using Preventive Asthma Drugs: Study 2Health News:More Children Using Preventive Asthma Drugs: Study 3
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
For the qualitative detection of antibodies to HIV-1 and HIV-2 in human serum, plasma and whole blood specimens...
... HumaPen MEMOIR is the first and only insulin pen ... and amount of your last 16 doses (including priming ... insulin you last took. With HumaPen MEMOIR, you simply ... one-unit increments (up to 60 units) after initial set-up. ...
PulmoLife is a new COPD screening device, designed for quick and easy screening of adult smokers for early detection of COPD....
Medicine Products: